|
1 Nicholson JK，Lindon JC，Holmes E. 'Metabonomics' : Understanding the metabolic responses of living systems to pathophysiologicalstimuli via multivariate statistical analysis of biological NMR spectroscopic data[J]．Xenobiotica，1999，29(11)：1181-1189.
|
|
2 Fiehn O, Kopka J, Dormann P, et al. Metabolite profiling for plant functional genomics [J]. Nat Biotechnol, 2000，18(11)：11572-11611.
|
|
3 Fiehn O．Metabolomics: The link between genotypes and phenotypes[J]．Plant Mol Biol，2002，48(1-2)：155-171.
|
|
4 Dettmer K, Aronov PA, Hammock BD. Mass spectrometry-based metabolomics[J]. Mass Spectrom Rev, 2007，26：51-78.
|
|
5 Ryan D, Robards K. Metabolomics: The greatest omics of them all [J] ? Anal Chem，2006，78：7954-7958.
|
|
6 Fiehn O. Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks [J]. Comp Funct Genomics, 2001，2(3)：155-168.
|
|
7 Nicholson JK, Wilson ID. Understanding 'global' systems biology: Metabonomics and the continuum of metabolism[J]. Nat Rev Drug Discov, 2003，2(8)：668-676.
|
|
8 Tailor J, King RD, Altmann T, et al. Application of metabolomics to plant genotype discrimination using statistics and machine learning[J]. Bioinformatics, 2002，18 (Suppl 2)：S241-248.
|
|
9 Dunn WB, Bailey NJ, Johnson HE. Measuring the metabolome: Current analytical technologies [J]. Analyst，2005，130(5)：6062-6251.
|
|
10 Ackermann BL, Hale JE, Duffin KL. The role of mass-spectrometry in biomarker discovery and measurement[J]. Curr Drug Metab, 2006, 7(5): 5252-5391.
|
|
11 Dunn WB, Ellis DI. Metabolomics: Current analytical platforms and methodologies [J]. Trac Trends Anal Chem，2005，24(4)：2852-2941.
|
|
12 Hollywood K, Brison DR, Goodacre R. Metabolomics: Current technologies and future trends [J]. Proteomics，2006，6(17)：47162-47231.
|
|
13 Govil G．Metabonomics: A new frontier of nuclear magnetic resonance (NMR) [J]. Natl Acad Sci Lett India, 2004, 27(9210)：2892-2991.
|
|
14 Plumb RS, Stumpf CL, Granger JH, et al. Use of liquid chromatography/ time 2 of 2 flightmass spectrometry and multivariate statistical analysis shows promise for the detection of drug metabolites in biological fluids [J]. Rapid Commun Mass Spcctrom, 2003, 17(26)：2632-2638.
|
|
15 Beckwith-Hall BM, Brindle JT, Barton RH, et al. Application of orthogonal signal correction to minimise the effects of physical and biological variation in high resolution H1 NMR spectra of biofluids [J]. Analyst, 2002, 127(10)：12832-12881.
|
|
16 Lindon J, Holmes E, Nicholson J. Pattern recognition methods and applications in biomedical magnetic resonance[J]. Prog Nucl Magnetic Reson Spectrosc, 2001，39：1-40.
|
|
17 Rudan I, Boschi-Pinto C, Biloglav Z, et al. Epidemiology and etiology of childhood pneumonia [J]. Bull World Health Organ, 2008, 86(5): 408-416.
|
|
18 Slupsky CM, Cheypesh A, Chao DV, et al. Streptococcus pneumoniae and Staphylococcus aureus pneumonia induce distinct metabolic responses [J]. J Proteome Res, 2009，8(6)：3029-3036.
|
|
19 Slupsky CM. NMR-based analysis of metabolites in urine provides rapid diagnosis and etiology of pneumonia [J]. Biomark Med, 2010，4(2)：195-197.
|
|
20 Slupsky CM, Rankin KN, Fu H, et al. Pneumococcal pneumonia: Potential for diagnosis through a urinary metabolic profile [J]. J Proteome Res, 2009，8(12)：5550-5558.
|
|
21 Cassiday L. Diagnosing pneumonia with urinary metabolomics [J]. J Proteome Res, 2009，8(12)：5409-5410.
|
|
22 Serkova NJ, Van Rheen Z, Tobias M, et al. Utility of magnetic resonance imaging and nuclear magnetic resonance-based metabolomics for quantification of inflammatory lung injury[J]. Am J Physiol Lung Cell Mol Physiol，2008，295(1)：L152-561.
|
|
23 Horvath I, Barnes P, Hunt J. Exhaled breath condensate: Methodological recommendations and unresolved questions [J]. Eur Respir J，2005，26：523-548.
|
|
24 Carraro S, Rezzi S, Reniero F, et al. Metabolomics applied to exhaled breath condensate in childhood asthma [J]. Am J Respir Crit Care Med，2007，175：986-990.
|
|
25 De Laurentiis G, Paris D, Melck D, et al. Metabonomic analysis of exhaled breath condensate in adults by nuclear magnetic resonance spectroscopy [J]. Eur Respir J，2008，32：1175-1183.
|
|
26 Saude EJ, Obiefuna IP, Somorjai RL, et al. Metabolomic biomarkers in a model of asthma exacerbation: Urine nuclear magnetic resonance [J]. Am J Respir Crit Care Med, 2009，179(1)：25-34.
|
|
27 Wolak JE, Esther CR Jr, O'Connell TM. Metabolomic analysis of bronchoalveolar lavage fluid from cystic fibrosis patients [J]. Biomarkers, 2009, 14(1)：55-60.
|
|
28 Lin ZY, Xu PB, Yan SK, et al. A metabonomic approach to early prognostic evaluation of experimental sepsis by (1)H NMR and pattern recognition[J]. NMR Biomed，2009，22(6)：601-608.
|
|
29 Hinkelbein J, Feldmann RE Jr, Peterka A, et al. Alterations in cerebral metabolomics and proteomic expression during sepsis[J]. Curr Neurovasc Res，2007，4(4)：280-288.
|
|
30 Kawashima H, Oguchi M, Ioi H, et al. Primary biomarkers in cerebral spinal fluid obtained from patients with influenza-associated encephalopathy analyzed by metabolomics. Int J Neurosci[J]. 2006，116(8)：927-936.
|
|
31 Coen M, O'Sullivan M, Bubb WA, et al. Proton nuclear magnetic resonance-based metabonomics for rapid diagnosis of meningitis and ventriculitis[J]. Clin Infect Dis, 2005，41(11)：1582-1590.
|
|
32 Himmelreich U, Malik R, Kühn T, et al. Rapid etiological classification of meningitis by NMR spectroscopy based on metabolite profiles and host response[J]. PLoS One, 2009，4(4)：e5328.
|
|
33 Van der Ham M, de Koning TJ, Lefeber D, et al. Liquid chromatography-tandem mass spectrometry assay for the quantification of free and total sialic acid in human cerebrospinal fluid[J]. J Chromatogr B Analyt Technol Biomed Life Sci, 2010，878(15-16)：1098-1102.
|